Introducing Medscape for iPhone™ and iPod touch® Experience Now »
 
American Society for Radiation Oncology (ASTRO) 51st Annual Meeting
November 1 - 5, 2009; Chicago, Illinois

Multimedia: Video and SlideShows

Previous
Forward
  • The Medscape Cancer Survivorship Survey The Medscape Cancer Survivorship Survey   In his latest video blog, Dr. Maurie Markman encourages viewers to participate in the Medscape survey for healthcare providers that discusses cancer survivor care.
    Medscape Hematology-Oncology, November 2009
  • Joint Pain Associated With Aromatase Inhibitors in Patients With Breast Cancer Joint Pain Associated With Aromatase Inhibitors in Patients With Breast Cancer   In her latest video blog, Dr. Kathy Miller comments on a new study examining the incidence of arthralgia associated with aromatase inhibitor therapy in patients with breast cancer.
    Medscape Hematology-Oncology, November 2009
  • Will There Ever Be a Big Brown Ribbon Outside the White House? Will There Ever Be a Big Brown Ribbon Outside the White House?   In his latest video blog, Dr. John Marshall questions why the pink ribbon/breast cancer awareness promotion attracts more publicity than any other disease campaign.
    Medscape Hematology-Oncology, November 2009
  • Can Doctors Ever Tell Patients They Are Cured of Cancer? Can Doctors Ever Tell Patients They Are Cured of Cancer?   In her first Medscape video blog, Dr. Kathy Miller asks whether doctors should avoid using the term cured to describe patients who have been in remission for several years.
    Medscape Hematology-Oncology, November 2009
  • Using SERMs to Prevent Breast Cancer Using SERMs to Prevent Breast Cancer   What are the benefits and risks of SERMs in the primary prevention of invasive breast cancer in high-risk women? Dr. Andrew Kaunitz discusses the results of a systematic review in this video blog.
    Medscape Ob/Gyn & Women's Health, October 2009
  • The Value of Final Exams The Value of Final Exams   In his latest video blog, Dr. John Marshall compares the work involved in writing successful grant proposals to the preparations necessary for final exams.
    Medscape Hematology-Oncology, October 2009
  • Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer   A weekly regimen provided longer progression-free survival and overall survival than standard treatment in patients with ovarian cancer. Dr. Maurie Markman summarizes the Sept. 20 Lancet article.
    Medscape Hematology-Oncology, September 2009
  • PET Scan vs CT Scan in NSCLC Staging and Genetic Testing for Warfarin PET Scan vs CT Scan in NSCLC Staging and Genetic Testing for Warfarin   In this video blog, Dr. Andy Shorr discusses a study on the use of the PET scan and the CT scan in the staging of NSCLC. He also provides insight into the pharmacogenetics of warfarin.
    Medscape Pulmonary Medicine, September 2009
  • How Safe Is the HPV Vaccine? How Safe Is the HPV Vaccine?   Dr. Maurie Markman highlights the results of a surveillance study on the safety of the HPV vaccine in his latest video blog.
    Medscape Hematology-Oncology, August 2009
  • Tweaking Adjuvant Strategies for Pancreatic Cancer Tweaking Adjuvant Strategies for Pancreatic Cancer   In this video blog, Dr. John Marshall explains how administration of available drugs, plus or minus radiation, might be modified to improve prognosis for patients with resected pancreatic cancer.
    Medscape Hematology-Oncology, August 2009
  • Colon Cancer Screening: Is It Only a Swallow Away? Colon Cancer Screening: Is It Only a Swallow Away?   Will colon capsule endoscopy replace colonoscopy for colorectal cancer screening? David A. Johnson, MD, discusses the pros and cons of this emerging technology in his latest video blog.
    Medscape Gastroenterology, August 2009
  • Safety, Efficacy, and &Value?? Safety, Efficacy, and &Value??   In this video blog, Dr. John Marshall suggests that cancer specialists should help set the bar with respect to incorporating the value of a therapy into the decision-making process.
    Medscape Hematology-Oncology, July 2009

Community Blogs

More Community Blogs

Physician Connect

More Discussions
All Clinical Discussions
 

Commentary and Interviews

More Commentary and Interviews

POLL

The FDA recently updated its expanded-access rules for investigational drugs by patients with cancer or other serious illnesses, but drugmakers are still sometimes reluctant to allow access because of high risk and low incentives. Do you think the FDA updates are likely or not likely to make investigational drugs more accessible?
A. Very likely
B. Somewhat likely
C. Not very likely
D. Not at all likely
E. Uncertain
or  View Results
Related Link: Related Medscape Article
 
 
 
 
Latest from NCCN at
Medscape.com/NCCN
Latest from Susan G. Komen
for the Cure at
Medscape.com/Komen

Also of Interest

 

Guidelines in the News

 

Business of Medicine

 

Genomics

More Genomics Articles
 
 
Medscape    MedscapeCME    eMedicine    Drugs    MEDLINE    All
All material on this website is protected by copyright, Copyright © 1994-2009 by Medscape. This website also contains material copyrighted by 3rd parties.